July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Emma Groarke on Ruxolitinib Study for Refractory T-LGL Leukemia from France
Apr 26, 2024, 06:33

Emma Groarke on Ruxolitinib Study for Refractory T-LGL Leukemia from France

Emma Groarke, Hematologist at the National Institutes of Health (NIH), shared a post on X/Twitter:

Nice paper from France in British Journal of Haematology on a series of relapsed/refractory T- Large granular lymphocytic leukemia (LGL) patients treated with Ruxolitinib.

Some response observed in 86% though complete response in 14%.

A potentially good option for patients going forward.”

Additional information.